Cervix Research Paper

The U.S. Preventative Services Task Force (USPSTF) recommends cervical cancer screening with cytology testing (also known as a Pap Smear) every three years in women ages 21 to 65 (U.S. Preventative Services Task Force [USPSTF], 2016a). The USPSTF has graded this recommendation with an “A” indicating that they have a high level of certainty that the screening will prove to be beneficial, rather than harmful to the patient (USPSTF, 2016a). However, if this patient would prefer to receive cervical cancer screening every five years, the USPSTF also has a high level of certainty that this will prove to beneficial rather than harmful if human papillomavirus (HPV) and cytology are both performed during this screening (USPSTF, 2016a). The

Cervical cancer is when there are malignant cells present in the cervix; it is developed in the lining of the cervix. A cervix is a narrow opening located at the bottom of the uterus that leads into the vagina. Cervical cancer mostly affects women between the ages of 40 and 55. This cancer can be prevented by screening for precancerous cells, and it can also be cured if it is detected at an early stage. Over the past few decades the number of cervical cancer cases has declined dramatically due to a more widespread screening of the disease. Today, it is estimated that 10,000 new

However even though there are many problem with the Pap smear, the most important error is failure of women to get a Pap smear (Dziura, 2009). As it is harder to monitor any changes in the cervical cancer if you don’t turn up for regular

Early detection of breast and cervical cancer reduced the burden of disease in women. The practices of Screening shown reduce the level of mortality and improve quality of life. The Every Woman Matters (EWM)stared in 1992 it is a federally-funded program designed to remove barrier to early screening by providing awareness and make screening more financially accessible to woman who have limited or no health insurance. The eligible women receive pay for office visits with associated clinical breast examination, pelvic examination, Papanicolaou smear test, and lab fees (Backer et al., 2004). Age-appropriate mammography and limited number of diagnostic test is also covered under program. In this paper I will

Prophylactic vaccination against high risk human papilloma virus 16 and 18 represents an exciting means of protection against HPV related malignancy. However, this strategy alone, even if there is a level of cross protection against other oncogenic viruses, cannot completely prevent cervical cancer. In some countries cervical screening programs have reduced the incidence of invasive cervical cancer by up to 80 percent although this decline has now reached a plateau with current cancers occurring in patients who have failed to attend for screening or where the sensitivity of the tests have proved inadequate. Cervical screening is inevitably associated with significant anxiety for the many women who require investigation and treatment following abnormal cervical cytology. However, it is vitally important to stress the need for continued cervical screening to complement vaccination in order to optimize prevention in vaccines and prevent cervical cancer in older women where the value of vaccination is currently unclear. It is likely that vaccination will ultimately change the natural history of HPV disease by reducing the influence of the highly oncogenic types HPV 16 and 18. In the long term this is likely to lead to an increase in recommended screening intervals. HPV vaccination may also reduce

Cervical cancer is caused by the uncontrollable growth of cells in the cervix, the lower part of the uterus that opens into the vagina. Some signs of cervical cancer are abnormal bleeding in the vagina (between menstrual cycles, after sex, and after menopause), pain in the lower belly, pain during sex, and abnormal vaginal discharge.

At first glance, the guidelines seem logical because cervical cancer takes years to develop. However, a majority of the population is not vaccinated against the HPV virus, which is the lead cause of cervical cancer. Until

Almost all cervical carcinomas are caused by Human papillomavirus (HPV). Cervical cancer can be a life-threating disease. However, over recent years the occurrence of cervical cancer has declined as well as the chance of dying from it. A huge contributing factor to this decline is the importance of a regular pap smear. A pap smear can find cervical pre-cancer before it turns into cancer. Recently, a vaccine for HPV, has been on the market, which provides close to a 100% protection against pre-cancer and general warts. HPV and cervical cancer are two disease that are closely related. However, each disease effects not only similar populations, but also different populations, as well as having its own signs and symptoms, detection procedures,

With each new screening testing procedure comes the social, ethical and scientific implication of the screening process. The social aspect of the screening is the risk of being stigmatized, for example it was believed that if you go to the hospital to get a pap smear you are sexually promiscuous. However, pap smear is a screening testing for cervical cancer, it is used to analysis the existence of precancerous or cancerous cells in the cervix. It is an uncomplicated, brief and necessary screening test recommended for every woman after the age of 21 or is sexually active. Pap smear is screening procedure for cancer which satisfy the social, ethical and scientific aspects of screening. Although

Cervical cancer is one of the highly popular disease for the women. Different programmes has been made up to fight against this deadly disease. New Zealand has one of the best screening programmes in the world. The establishment of National Cervical Cancer Screening Programme in NZ in 1990 had reduced a significant number of 60% of women who develop cervical cancer and who die from it since it was built. More than 1 million New Zealander women are enrolled in this programme and 95 % are eligible. The Cervical Cancer screening programme aims to; informing women about the importance of having the cervical screening tests; promoting cervical screening tests on a regular basis to women aged 20–70; ensuring high-quality and culturally appropriate services; supporting women with abnormal tests; ensuring there is regular monitoring to see that the goals of the programme are being met. The NCSP also acknowledges the importance of the Treaty of Waitangi in providing a screening programme that is successful for all New Zealand women.

Among the many arguments for mandatory HPV vaccination, the foremost is that it is an important medical achievement and a major public health milestone. This vaccine has proven to be one-hundred percent effective in preventing the 4 HPV strains that are responsible for seventy percent of cervical cancers and ninety percent of genital warts. In addition, no serious side effects have been identified. Because this vaccine is a preventive measure, administration before onset of sexual activity is ideal; however, even females who have been sexually active can still benefit from this vaccination (Perkins et al., 2010). Nationally and internationally, the HPV vaccine will significantly reduce disease burden by reducing monetary and psychological costs of invasive procedures that remove precancerous and cancerous lesions. By combining vaccination with routine Pap smear screening, these public health efforts have the remarkable opportunity to eradicate cervical cancer (Ramet et al., 2011).

Although there are several known risk factors for getting cervical cancer, no one knows exactly why one woman gets it and another doesn't. One of the most important risk factors for cervical cancer is infection with a virus called HPV (human papillomavirus). HPV is a sexually transmitted disease that is incredibly common in the population, one study showed that 43% of college age women were infected in a 3-year period. HPV is the virus that causes genital warts, but having genital warts doesn't necessarily mean you are going to get cervical cancer. There are different subtypes, or strains, of HPV. Only certain subtypes are likely to cause cervical cancer, and the subtypes that cause warts are unlikely to cause a cancer. Often, infection with HPV causes no symptoms at all, until a woman develops a pre-cancerous lesion mostly of the cervix. Because infection with a STD is a risk factor for cervical cancer, any risk factors for developing STD are also risk factors for developing cervical cancer. Women who have had many or several male sexual partners, having sexual intercourse at an early age, or have had male sexual partners who are considered high risk (meaning that they have had several sexual partners and/or began having sexual intercourse at an early age) are at higher risks for developing Cervical

Cervical cancer is the only malignant tumor that can almost completely be prevented by safe, fairly simple and affordable means, and yet, one woman dies of this disease unnecessarily every two minutes in the world. Cervical cancer is the most common malignant tumor of the female reproductive system in the developing world and the leading cause of cancer- related deaths in sub- Saharan Africa. Cervical cancer is the most frequent cancer diagnosed in Tanzania and its mortality rate is unacceptably

In the United States, it is one of the eight-most common cancer of women. According to researches, the data shows that Hispanic women are significantly more likely to be diagnosed with cervical cancer than the general population and their median age at diagnosis is 48. In 1998, about 12,800 women were diagnosed in the US and about 4,800 died. Among cancers of the female reproductive tract, it is less common than endometrial cancer and ovarian cancer. The rates of new cases in the United States was 7 per 100,000 women in 2004. Cervical cancer deaths decreased by approximately 74% in the

Three separate randomized controlled trials for cervical screening have been conducted among Indian women of the